LignaMed LLC
LignaMed LLC
Categories
Biotech Pharmaceutical
About
LignaMed, LLC is a drug development company with a fast track strategy to market approval and an early exit. The company?s initial product, LGM-2605, will be utilized to reduce side effects and increase effectiveness of radiation treatment of chest cancers as well as for protection against radiological threats. The preclinical development of LGM-2605 has been generously supported by the Radiation Nuclear Countermeasure Program (RNCP), sponsored by the National Institute of Allergy and Infectious Diseases (NIAID)
Get Updates
from LSPA
Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry, and so much more!
Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Today it has grown to represent the entire life sciences industry – medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.